T-cell gene rearrangement in mycosis fungoides

Mycosis fungoides is a form of cutaneous T-cell lymphoma affecting skin. The test examines genetic rearrangements in T-cell receptors from a skin sample. A clonal pattern can add weight to a diagnosis when it fits the examination and biopsy findings, while a negative result does not rule the condition out. Similar patterns can sometimes occur in inflammatory skin disorders, so the result must be interpreted with the biopsy, appearance, distribution, symptoms, and clinical history.

Your report may refer to clonality, a detected rearrangement, or an indeterminate result. These terms describe the laboratory finding rather than the full stage or outlook of the illness.

Ask which sample was tested, whether the finding matched the biopsy, and whether another sample or specialist review is useful. Keep copies of pathology reports and note changes in patches, plaques, itch, or thicker areas. Treatment depends on the extent and behaviour of skin disease; options may include prescribed creams or light-based care such as narrowband UVB phototherapy or PUVA therapy. Treatment choices should be personalised by a clinician familiar with cutaneous lymphoma.

Arrange prompt dermatology review for rapidly changing lesions, new tumours, extensive redness, persistent open areas, swollen lymph nodes, fever, or unexplained weight loss. Seek urgent help for severe illness, sudden weakness, breathing difficulty, or confusion. These symptoms need assessment because they can have causes unrelated to the test result as well.

Ask: What did the rearrangement test show? How does it fit my biopsy and examination? Does the result change my diagnosis or stage? Should the sample be reviewed or repeated? Which skin treatments suit my current findings, and how will we monitor response?